Shifamed
Overview
Shifamed is a specialized medical innovation hub dedicated to developing solutions that accelerate time to market, reduce risk, and increase impact in the healthcare industry. Founded by serial entrepreneur Amr Salahieh, the company operates as a corporate venture capital firm, investing in and nurturing early-stage medical device and biotechnology companies. Shifamed's portfolio includes companies like Supira Medical, Adona Medical, and Akura Medical, which are focused on innovative solutions for heart failure management and interventional cardiology. The firm's investment strategy emphasizes supporting companies through various stages of development, from seed funding to later-stage financing rounds. For instance, Supira Medical secured a $120 million Series E financing round in March 2025, led by new investors Novo Holdings and Qatar Investment Authority, along with participation from existing investors. Similarly, Adona Medical raised $33.5 million in Series C financing in July 2024, led by Cormorant Asset Management and TCP Health Ventures. These investments aim to advance product development and clinical programs for next-generation medical devices. Shifamed's approach combines human-centered design with a deep understanding of the medical device industry, fostering innovation that addresses unmet clinical needs. By providing strategic guidance, operational support, and access to a network of industry experts, Shifamed plays a pivotal role in bringing transformative healthcare solutions to market, ultimately improving patient outcomes and quality of life.
Investment Focus
- Innovative medical technologies
- Strong management teams
- Clear clinical and regulatory pathways
Portfolio Companies
Reach Shifamed directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Shifamed
What sectors does Shifamed invest in?
Shifamed invests in Healthcare, Medical Devices and Biotechnology, and is based in Campbell, California, United States. Shifamed is listed as a corporate vc in the ConnectSafely investor database.
What stage does Shifamed invest at?
Shifamed backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 2.5M - 120M.
Which regions does Shifamed invest in?
Shifamed invests across United States.
Who are the partners at Shifamed?
Team members listed for Shifamed include Claudio Argento (CTO) and David Voris (Chief Financial Officer).
What companies has Shifamed invested in?
Shifamed's portfolio includes Supira Medical, Adona Medical, Akura Medical, Tioga Cardiovascular and Myra Vision.
How do I contact Shifamed?
Shifamed's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
